copy of dr. hamilton on fda approval of atezolizumab/nab-paclitaxel in tnbc
Published 5 years ago • 62 plays • Length 0:13Download video MP4
Download video MP3
Similar videos
-
1:17
dr. hamilton on fda approval of atezolizumab/nab-paclitaxel in tnbc
-
1:16
dr. lynce on fda approval of atezolizumab/nab-paclitaxel in tnbc
-
2:38
dr. mittendorf highlights fda approval of atezolizumab/nab-paclitaxel in pd-l1 tnbc
-
1:08
dr. horn on the fda approval of atezolizumab plus bevacizumab and chemotherapy in nsclc
-
1:10
dr. hamilton on the fda approval of tucatinib in her2 breast cancer
-
0:43
dr. hamilton on fda approval of adjuvant pertuzumab regimen in her2 early breast cancer
-
1:48
dr. saeed rafii on atezolizumab/ nab-paclitaxel in tnbc
-
7:08
impassion130: results of atezolizumab plus nab-paclitaxel for frontline tnbc
-
1:27
fda approval of atezolizumab for nsclc
-
3:12
atezolizumab with nab-paclitaxel improves survival in breast cancer patients
-
7:05
the fda approval of atezolizumab in bladder cancer
-
1:03
dr. kalinsky on clinical impact of atezolizumab combo in tnbc
-
5:59
impassion130: atezolizumab and nab-paclitaxel in triple-negative breast cancer
-
5:45
case 3: atezolizumab/nab-paclitaxel for triple negative breast cancer
-
6:49
fda approval of atezolizumab for advanced bladder cancer
-
0:35
dr. farago on the fda approval of pembrolizumab for lower pd-1 cutoff nsclc
-
3:16
survival with atezolizumab and nab-paclitaxel versus nab-paclitaxel alone among patients with advanc
-
8:42
chemoimmunotherapy in tnbc: the impassion130 trial
-
1:02
dr. mitri on impact of trastuzumab biosimilar fda approval